Xubin Bao

1 works

State Key Laboratory of Drug Research, Cancer Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China

1. Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone

   Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9

   ArticlePARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry20222 citations

   ABIABI:AkademIndex/openalex/2026.other.075060